PlainRecalls
FDA Drug Critical Class I Terminated

NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192-327-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

Reported: June 2, 2021 Initiated: April 29, 2021 #D-0395-2021

Product Description

NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192-327-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

Reason for Recall

Subpotent Drug

Details

Units Affected
a) 66,155 bottles; b) 26,212 bottles
Distribution
Nationwide within the United States including Puerto Rico
Location
Alpharetta, GA

Frequently Asked Questions

What product was recalled?
NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192-327-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005. Recalled by Acella Pharmaceuticals, LLC. Units affected: a) 66,155 bottles; b) 26,212 bottles.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on June 2, 2021. Severity: Critical. Recall number: D-0395-2021.